DSM
帝斯曼
基本信息
- 批准号:8753117
- 负责人:
- 金额:$ 4.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-04 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AmendmentBudgetsCancer CenterCancer Center Support GrantClinicalClinical Informatics Shared ResourceClinical Nursing ResearchClinical ProtocolsClinical ResearchClinical TrialsClinical Trials NetworkComplementConsentDataDatabasesDevelopmentDiagnostic and Statistical Manual of Mental DisordersEligibility DeterminationEnsureFundingGoalsInformation SystemsInstitutionInstitutional Review BoardsLeadershipMalignant NeoplasmsModelingMonitorNamesNursing ResearchPatientsPhasePhysician ExecutivesProcessProtocols documentationQuality ControlReportingResearchResearch InfrastructureResearch PersonnelResource AllocationResource SharingSafetySecurityServicesSupervisionSystemTimeLineTrainingTraining SupportTraining and EducationTranslational ResearchUpdateWorkcancer sitedata integritydata managementdesignimprovedmemberoncologyoperationpatient safetyprograms
项目摘要
The Clinical Protocol Data Management (CPDM) Office provides infrastructural support for the conduct of
clinical research at the HICCC. Its functions include: (1) clinical trial development (from concept to IRB
approval), execution, and monitoring; (2) liaising with the HICCC Clinical Informatics Shared Resource
(CISR) to ensure the optimal operation of clinical research information systems and databases, and (3)
interfacing with regulatory and sponsoring agencies.
To successfully accomplish these functions, the CPDM has developed 5 cores overseen by the Director of
Clinical Operations and ultimately the Medical Director: Research Nursing, Clinical Research Coordination,
Regulatory, Compliance, and Finance. The Research Nursing and Clinical Research (Data Management)
cores consist of 8 Research Nurses, 2 Research Nurse Managers, 24 Clinical Research Coordinators (Data
Managers), and 2 Clinical Research Coordinator Managers; these cores are responsible for trial
assignments, supervision, and training. The Regulatory core consists of 8 Regulatory Research Coordinators
and 1 Regulatory Manager; this core is responsible for interfacing with the IRB and maintaining files on each
protocol executed by the CPDM (protocol, consents, amendments, annual reviews, etc.). The Compliance
core consists of 3 Compliance Coordinators and 1 Compliance Manager; this core is responsible for
monitoring investigator-initiated trials(IIT) per our NCI-approved DSMP and managing central registration
processes, including eligibility review. The Finance core consists of 1 Finance Manager who is responsible
for managing the CPDM operating budget and providing financial oversight of our trial portfolio. The CPDM
works very closely with the HICCC Clinical Informatics Shared Resource (CISR), which is responsible for
NCI reporting (including CTRP) and Velos support (training, CFR design, interface development, and
security/oversight). The CPDM complements the PRMS, while providing investigators with efficient,
seamless, and responsible clinical trial oversight for the Cancer Center.
The Data and Safety Monitoring Committee (DSMC) Is responsible for data and safety monitoring of ongoing
clinical trials. The DSMC prioritizes local investigator-initiated phase I, II, and III clinical trials. The committee
will assume responsibility for other interventional trials when it is deemed appropriate by the Protocol Review
and Monitoring System Committee (PRMSC), IRB or at the request ofthe PI.
临床方案数据管理 (CPDM) 办公室为开展临床方案数据管理 (CPDM) 提供基础设施支持
HICCC 的临床研究。其职能包括:(1)临床试验开发(从概念到IRB)
批准)、执行和监控; (2) 与 HICCC 临床信息学共享资源联络
(CISR) 确保临床研究信息系统和数据库的最佳运行,以及 (3)
与监管和赞助机构建立联系。
为了成功完成这些职能,CPDM 开发了 5 个核心,由主任监督。
临床操作以及最终的医疗总监:研究护理、临床研究协调、
监管、合规和财务。研究护理和临床研究(数据管理)
核心人员包括 8 名研究护士、2 名研究护士经理、24 名临床研究协调员(数据
经理)和 2 名临床研究协调经理;这些核心负责审判
任务、监督和培训。监管核心由 8 名监管研究协调员组成
1 名监管经理;该核心负责与 IRB 接口并维护每个 IRB 上的文件
CPDM 执行的协议(协议、同意书、修正案、年度审查等)。合规性
核心由3名合规协调员和1名合规经理组成;该核心负责
根据 NCI 批准的 DSMP 监控研究者发起的试验 (IIT) 并管理中央注册
流程,包括资格审查。财务核心由 1 名财务经理组成,负责
用于管理 CPDM 运营预算并为我们的试验组合提供财务监督。 CPDM
与 HICCC 临床信息学共享资源 (CISR) 密切合作,该资源负责
NCI 报告(包括 CTRP)和 Velos 支持(培训、CFR 设计、界面开发和
安全/监督)。 CPDM 补充了 PRMS,同时为研究人员提供了高效、
对癌症中心进行无缝且负责任的临床试验监督。
数据和安全监测委员会 (DSMC) 负责正在进行的数据和安全监测
临床试验。 DSMC 优先考虑当地研究者发起的 I、II 和 III 期临床试验。委员会
当方案审查认为适当时,将承担其他介入试验的责任
监测系统委员会 (PRMSC)、IRB 或应 PI 的要求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN G EMERSON其他文献
STEPHEN G EMERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN G EMERSON', 18)}}的其他基金
Antigen Presenting Cells in the Induction of GVHD
抗原呈递细胞在 GVHD 诱导中的作用
- 批准号:
6860977 - 财政年份:2004
- 资助金额:
$ 4.78万 - 项目类别:
Antigen Presenting Cells in the Induction of GVHD
抗原呈递细胞在 GVHD 诱导中的作用
- 批准号:
7025003 - 财政年份:2004
- 资助金额:
$ 4.78万 - 项目类别:
Antigen Presenting Cells in the Induction of GVHD
抗原呈递细胞在 GVHD 诱导中的作用
- 批准号:
6773630 - 财政年份:2004
- 资助金额:
$ 4.78万 - 项目类别:
Antigen Presenting Cells in the Induction of GVHD
抗原呈递细胞在 GVHD 诱导中的作用
- 批准号:
7176119 - 财政年份:2004
- 资助金额:
$ 4.78万 - 项目类别:
Stem cell manipulation via HOX gene regulation
通过 HOX 基因调控进行干细胞操作
- 批准号:
7669125 - 财政年份:2001
- 资助金额:
$ 4.78万 - 项目类别:
相似海外基金
Can megafauna shift the carbon and surface radiation budgets of the Arctic?
巨型动物群能否改变北极的碳和地表辐射预算?
- 批准号:
NE/W00089X/2 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Research Grant
Resilience of pollinators in a changing world: impact of developmental environment on metabolism and energetic budgets in social and solitary bees
不断变化的世界中授粉媒介的复原力:发育环境对群居和独居蜜蜂新陈代谢和能量预算的影响
- 批准号:
BB/X016641/1 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Research Grant
An innovative EDI data, insights & peer benchmarking platform enabling global business leaders to build data-led EDI strategies, plans and budgets.
创新的 EDI 数据、见解
- 批准号:
10100319 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Collaborative R&D
Nutrient budgets as a tool for minimizing nitrogen and phosphorus losses from agricultural fields
养分预算作为最大限度减少农田氮磷损失的工具
- 批准号:
574867-2022 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
University Undergraduate Student Research Awards
Sea-ice Snow Microbial Communities’ Impact on Antarctic Bromocarbon Budgets and Processes
海冰雪微生物群落对南极溴碳预算和过程的影响
- 批准号:
2031121 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
Standard Grant
Collaborative Research: ORCC: The role of bioenergetic budgets in defining elevation limits and modeling geographic ranges of species
合作研究:ORCC:生物能预算在定义海拔限制和建模物种地理范围中的作用
- 批准号:
2222475 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
Standard Grant
Collaborative Research: ORCC: The role of bioenergetic budgets in defining elevation limits and modeling geographic ranges of species
合作研究:ORCC:生物能预算在定义海拔限制和建模物种地理范围中的作用
- 批准号:
2222476 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
Continuing Grant
CNS Core: Small: Budgets, Budgets Everywhere: A Necessity for Safe Real-Time on Multicore
CNS 核心:小:预算,预算无处不在:多核安全实时的必要性
- 批准号:
2151829 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
Standard Grant
The Effect of Aggressive Mitigation of non-CO2 Emissions on Global Carbon Budgets
积极减少非二氧化碳排放对全球碳预算的影响
- 批准号:
559571-2021 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
Postgraduate Scholarships - Doctoral
Can megafauna shift the carbon and surface radiation budgets of the Arctic?
巨型动物群能否改变北极的碳和地表辐射预算?
- 批准号:
NE/W00089X/1 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
Research Grant














{{item.name}}会员




